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Abstract
Common characterization techniques used to detect crystallinity in amorphous solid dispersions 
(ASD) typically have detection or quantification limits on the order of 1%. Herein, an amorphous 
solid dispersion of indomethacin and polyvinylpyrrolidone/vinyl acetate copolymer (PVPVA) 
produced by hot melt extrusion was determined to be amorphous by X-ray powder diffraction 
(XRPD) and differential scanning calorimetry (DSC). However, through the use of transmission 
electron microscopy (TEM), residual crystals of two populations were identified: single crystals 
mid-dissolution (<100 nm) and nanocrystalline domains of 5-10 nm in size. Both domain types 
were observed to contain a high defect density. Polarized light microscopy (PLM) and scanning 
electron microscopy (SEM) techniques supplement these findings by corroborating crystallinity. 
The use of high resolution analytical techniques to identify and characterize residual crystallinity 
is considered an important first step to understanding the significance of these residual 
crystalline populations to ASD performance attributes.
Keywords
Amorphous solid dispersion; hot melt extrusion; residual crystallinity; transmission electron 
microscopy; crystal dissolution
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Introduction
Amorphous solid dispersions (ASDs) are an increasingly popular formulation strategy used 
to overcome poor aqueous solubility and slow dissolution of many drugs, improving 
bioavailability and therapeutic efficacy.1,2 By crystalline-to-amorphous solid state transformation 
and subsequent stabilization by dispersion within an amorphous polymer, the solubility 
advantage of the amorphous form often can be realized.3,4 Hot melt extrusion (HME) processes 
utilize thermal and mechanical input to form ASDs by melting and/or dissolving the drug into 
the molten polymer.5 Given sufficient thermal input and mixing, a homogenous molecular 
dispersion should result free of residual crystallinity.6 However, if the transformation is 
incomplete, residual crystalline content may contribute to potential stability or dissolution 
performance issues.7–9
X-ray powder diffraction (XRPD) is the gold standard technique for crystallinity detection 
and quantification in ASD formulations.10 However, the technique is limited by mass fraction 
and dilution, crystal quality, as well as method parameters.10–12 A complementary set of 
techniques would commonly be used to characterize a formulation, but have their own 
limitations which stem from properties of the instrument or sample. Polarized light microscopy 
(PLM) may be highly sensitive for detection of crystalline content, even when XRPD has 
determined a sample to be amorphous,13 but this technique is limited by spatial resolution caused 
by the diffraction limitation. Differential scanning calorimetry (DSC) is limited by mass fraction, 
domain size, and the dynamic heating process.6,14 Other studies have demonstrated that 
molecular-level differences in the amorphous phase can be identified by more sensitive 
techniques, such as Raman spectroscopy, even when XRPD and DSC have failed to identify 
these differences.15,16
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The use of higher resolution analytical techniques may overcome some of these limitations in 
order to characterize residual crystalline content. Microscopy techniques such as transmission 
electron microscopy (TEM) have recently been found to be capable of detecting crystalline 
phases within ASDs.17,18 Fast Fourier Transform (FFT) analysis reveals periodic structure within 
TEM images, which may or may not be clearly visible in image space. The Fourier space image 
will produce sharp spots at frequencies corresponding to the lattice periodicities within the 
image, which in turn enables crystallinity to be confirmed and domains spatially identified within 
the micrograph. The inherent challenge of TEM is in preparing an electron-transparent sample on 
the order of 100 nm in thickness; however the technique allows atomic distances to be 
visualized.19,20
Herein, an X-ray amorphous extrudate of a 1:1 blend of indomethacin (IDM) and 
polyvinylpyrrolidone/vinyl acetate copolymer (PVPVA) was prepared using HME processing 
conditions that correspond to the solubility temperature, i.e. the lowest temperature where a 
homogenous molecular dispersion could theoretically be prepared.6 Under these conditions, there 
is a significant risk of residual crystallinity if insufficient time or mixing conditions are provided. 
By processing for a long residence time to account for the kinetics of drug crystal dissolution, the 
extrudate was found to be amorphous by XRPD and DSC. However, through the use of high 
resolution characterization techniques, namely transmission electron microscopy (TEM), 
evidence of nanometer-scale crystallinity was found.
Experimental
Materials
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Indomethacin (IDM, Tm = 161°C) was obtained from ChemShuttle (Hayward, CA). 
Polyvinylpyrrolidone/vinyl acetate copolymer (PVPVA, Kollidon VA64, Tg = 104°C) was a gift 
from BASF (Florham Park, NJ).
Methods
Hot Melt Extrusion
An Xplore Pharma Melt Extruder (Geleen, The Netherlands), assembled with the 5 mL co-
rotating conveying screw and barrel set, was used at a screw speed of 20 rpm to prepare an 
extrudate of a 1:1 IDM:PVPVA premix (water corrected weight ratio). A schematic of the 
extruder used in this study is found in Figure 1a, and the temperature and time process conditions 
used are shown in the process operating design space diagram Figure 1b). A water bath set to 
10°C cooled the hopper, and the heating zone temperature was set to 134°C, resulting in a bulk 
product melt temperature of 131°C (as monitored by an in-line thermocouple located after the 
screw and prior to the recirculation channel or die). The recirculation valve was in the open 
position to extend the processing time; the valve was closed after 20 minutes to stop the 
recirculation and begin extruding the melt. The extrudate was allowed to cool at room 
temperature. A portion of the extrudate was cryomilled using a SPEX 6750 Freezer/Mill 
(Metuchen, NJ) for 60 seconds of grinding time at 10 Hz under liquid nitrogen to form a fine 
powder. Powders were then brought to room temperature and sieved to achieve particle size 
fractions of 100-250 µm and <100 µm. Extrudates and powders were stored in a refrigerator 
under desiccant until analysis.
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Figure 1. (a) Schematic of the hot melt extruder. (b) The process conditions of the 
IDM:PVPVA extrudate (ASD) are represented within a process operating space diagram, 
constructed based on the characterization of many samples found in our previous work.6
X-ray Powder Diffraction (XRPD)
X-ray powder diffraction (XRPD) patterns were collected using a Rigaku SmartLab 
diffractometer (Rigaku Americas, The Woodlands, Texas) in Bragg-Brentano mode with a Cu-
Kα radiation source and a d/tex ultra detector. Using a glass sample holder, the patterns of the 
extrudate powder (100-250 µm size fraction) were obtained from 5-40° 2θ, using a step size of 
0.02° and a scan rate of 0.5° per min. The limits of detection and quantification were found to be 
0.4% and 1%, respectively.6
Differential Scanning Calorimetry (DSC)
A TA Q2000 differential scanning calorimeter equipped with a refrigerated cooling 
accessory (TA Instruments, New Castle, DE) purged with nitrogen at 50 mL/min was used to 
detect the Tg of the extrudate powder (<100 µm size fraction), as well as the constituent 
components. Each sample (3-5 mg, <100 µm size fraction) was loaded into a standard aluminum 
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pan and heated from 0-180°C at 5°C/min with modulation of ±0.796 every minute, then cooled 
to 0°C at 10°C/min, followed by a second heating ramp at 10°C/min.
Polarized Light Microscopy (PLM)
The 100-250 µm size fraction powder samples or indomethacin particles were loaded in 
mineral oil on a glass slide and visually observed for birefringence using a Nikon Eclipse E600 
POL cross-polarized light microscope (20X objective) with Nikon DS-Ri2 camera (Melville, 
NY). At least 5 images were captured to characterize the sample.
Transmission Electron Microscopy (TEM)
Small pieces of the extrudate or indomethacin particles were sprinkled on a 300 mesh 
carbon-coated copper TEM grids with 5-6 nm standard thickness (SPI supplies, West Chester, 
PA). Extrudate pieces were placed on the TEM grid by gently touching/wiping the interior of the 
vial lid, which contained particulates fragmented from the bulk extrudate rods, with the carbon-
coated side of the grid. 
Bright-field transmission electron micrographs were acquired in an FEI Tecnai G20 electron 
microscope (FEI, Hillsboro, Oregon, USA) equipped with a LaB6 source, X-max 80 mm2 silicon 
drift detector (Oxford Instruments, Abingdon, Oxfordshire, UK), and operated at 200 keV, 
100 µm aperture, and a spot size of 1 (drug crystal images) or 3 (extrudate images). At least three 
grid squares were analyzed to identify particles that were suitably electron transparent for 
imaging.
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Fast Fourier Transform (FFT) analysis was performed using the Gatan DigitalMicrograph 
3.21 software suite (Pleasanton, CA). Fourier filtering was applied using a spot mask symmetric 
about the origin of the FFT image, which selects only the desired frequencies (in reciprocal 
space). By then performing an inverse FFT on the masked image, the filtered image is 
reconstructed (in real space) which reveals only the periodic content associated with the specific 
FFT spot pair. ImageJ 1.51 (National Institutes of Health, Bethesda, MD) was used to apply false 
color imaging.
Scanning Electron Microscopy
Indomethacin particles or a cross section of the extrudate were fixed on a SEM stub using 
double sided carbon tape, sputter-coated with platinum target for 60 seconds and examined with 
a FEI Nova nanoSEM field emission scanning electron microscope (FEI Company, Hillsboro, 
Oregon) operating at a 5 kV accelerating voltage, ∼5 mm working distance, and a spot size of 3. 
High resolution through-the-lens detector (TLD) and Everhart Thornley detector (ETD) were 
used to image the extrudate and indomethacin particles, respectively.
Results and Discussion
Characterization of Indomethacin Crystals
The IDM starting material was primarily composed of plate-like particles (Figure 2a,b), 
which consist of single crystals coated with smaller crystals as observed by extinguishing 
birefringence during rotation under polarized light (Figure 2a). The crystal lattice planes seen by 
TEM (Figure 2c-e) show microstructure consistent with crystals in a variety of orientations, 
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consistent with the observations from SEM and PLM, where small crystals are agglomerated or 
electrostatically affixed to the surface of larger crystals, and surface imperfections are evident.
Figure 2. (a) Polarized light microscopy images of an IDM crystal, demonstrating 
extinguishing birefringence upon rotation. (b) Scanning electron microscopy (SEM) image 
of the IDM particles. (c) BF TE micrograph of an IDM particle. (d, e) BF TE micrograph of 
the crystalline microstructure and corresponding FFT pattern.
Sample Preparation & Characterization
By applying high temperatures and mixing in an HME process, crystalline drug particles melt 
and/or dissolve into the molten polymer. Based on the temperature-composition phase diagram 
constructed previously,6 processing conditions used to prepare the IDM:PVPVA extrudate were 
expected to generate a fully amorphous system. As shown in the process operating design space 
diagram (Figure 1b), within the dissolution regime, the crystalline drug can be fully solubilized 
at or above the formulation critical temperature Tc (131°C), given sufficient mixing and 
Page 9 of 27
ACS Paragon Plus Environment





























































Page 10 of 26
residence time. Samples prepared at this lower bound of processing temperature have the greatest 
risk of residual crystalline content, because drug crystal dissolution into a polymer melt is both a 
thermodynamically and kinetically driven process.
An ASD prepared at the formulation critical temperature Tc (131°C) with 10 minutes of 
residence time was found to be X-ray amorphous, but had some birefringence detected using 
PLM. Hence, for TEM studies, the processing time was extended to 20 minutes. This extended 
processing time was selected to achieve complete dissolution of any residual crystals that may 
have been present after 10 minutes of processing time (below the XRPD limit of detection, 0.4%, 
but visible by PLM). Characterization by common analytical tools supported this supposition: no 
evidence of crystallinity is seen by XRPD (Figure 3a), a single composite glass transition Tg is 
observed by DSC (Figure 3b), trace or no birefringence is seen by PLM (Figure 3c), and the 
extrudate is clear by visual assessment (Figure 3d).
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Figure 3. Characterization of the IDM:PVPVA extrudate (ASD). (a) X-ray powder 
diffraction patterns of PVPVA, ASD, physical mixture (PM), and pure IDM. The halo 
pattern of the ASD pattern indicates the sample is amorphous. (b) Reversing heat flow 
DSC thermogram of 1:1 IDM:PVPVA showing a single Tg. (c) Polarized light micrograph 
of 1:1 IDM:PVPVA. Trace birefringence is observed in some images. (d) The 1:1 
IDM:PVPVA extrudate appears clear, indicating the sample is amorphous. 
Extrudate Characterization by Transmission Electron Microscopy
Multiple particles of the ASD extrudate were imaged using transmission electron microscopy 
(TEM), and both amorphous and crystalline domains were detected within (Figures 4-6). 
Amorphous domains appear as a homogenous continuous phase, while evidence of crystallinity 
include darker areas within the matrix, diffraction contrast, and lattice planes.17,18,21 Each of these 
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particles show broadly consistent, yet unique morphology. In particular, highly defective 
nanometer-scale crystallites of two populations are identified. First, discrete crystals (<100 nm) 
are observed mid-dissolution. Second, nanocrystalline domains of approximately 5-10 nm in 
size, commonly in clusters, are observed. When observing small crystalline phases, it is often 
difficult to confirm the crystallinity by FFT, for a variety of reasons: the crystal orientation may 
have frequencies beyond those which can be recorded in the image, the specimen thickness may 
vary causing some areas to be too thick to record a lattice image, the sub-surface placement of 
the crystal within the particle obscures the lattice, the remaining degree of order in the domain, 
and the interference of the drug-polymer amorphous matrix.
The ASD particle shown in Figure 4a shows evidence of amorphous material and both 
populations of crystalline domains. The population of nanocrystalline domains is shown in 
Figure 4b. The FFT pattern (inset) confirms that many of the domains in this region are 
crystalline. The domains are clustered within the particle, suggesting that these domains 
originated from the same crystal and have not yet distributed and dissolved into the matrix. The 
domains in this image are 5.8 ± 1.2 nm in size (± SD, n = 20), and are randomly oriented, as 
demonstrated in the FFT. The random orientation, similarity of domain size, and clustering 
suggests a mechanical origin of these crystals. 
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Figure 4. (a) BF TE micrograph of an ASD particle with residual crystallinity. (b) BF TE 
micrograph of the nanocrystalline domains and corresponding FFT pattern (inset). (c) BF 
TE micrograph of the ~ 26x70 nm discrete crystal and corresponding FFT pattern (inset). 
(d) Reconstructed BF TE micrographs from the inset of (C) generated using the Inverse 
FFT function in the Gatan Suite. Each of the areas A-D are colorized to indicate the 
location where those patterns appear in the original image (c). Bend contours in A are 
highlighted by blue arrows; lattice defects, such as edge dislocations, are highlighted by 
white arrows.
A closer view of a discrete 26x70 nm crystal from this ASD particle is shown in Figure 4c, 
which clearly shows both amorphous and crystalline regions (confirmed by the FFT pattern 
inset). By applying an inverse FFT to each of these spots, the image can be reconstructed to 
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show only the areas producing that order (Figure 4d: A-D). The lattice planes, now individually 
visualized, show dislocations and different degrees of thermally- and/or mechanically-induced 
structural deformation. The dark interference fringes seen in Error! Reference source not 
found.d panel A are bend contours, which indicate curvature of the crystal arising due to strain at 
the interface of the crystal.22,23 We hypothesize that this crystal, while defective, is still a single 
crystal. The reconstructed images Figure 4d panels C and D are two lattice planes of the crystal 
and are found in almost the entire area of the crystal shape, while the planes found in Figure 4d 
panels A and B (if superimposed) form a third, in-focus lattice plane.
Another ASD particle (Figure 5Error! Reference source not found.a) primarily contains 
areas that resemble crystalline domains, based on the appearance of the internal structure. A 
representative region is shown in Figure 5b. This partially crystalline area (also seen in the 
reconstructed false color images found in Figure 5c panels A-C) highlights a single lattice 
spacing in multiple orientations. This suggests that the crystal planes have been sheared with 
rotation in three distinct orientations. Each plane has a different level of dissolution, most clearly 
observed in Figure 5c panel C.
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Figure 5. (a) TEM image of an ASD particle with residual crystallinity. (b) Representative 
region of the particle and corresponding FFT pattern (inset). (c) Inverse FFTs of areas A-C 
colorized to indicate the location where those patterns appear in the original image. The 
dissolution front is most apparent in C, highlighted by white arrows.
The ASD particle shown in Figure 6a is also composed of amorphous and crystalline 
domains. Channels of amorphous material are observed, where polymer appears to have 
advanced into the crystalline regions. We hypothesize that the remaining crystalline domains in 
this particle may have originated from a discrete crystal, now segregated into smaller and 
partially dissolved domains. The appearance of the bend contours in Figure 6b are likely a result 
of crystal edges formed by dissolution of the crystal and strain at the interface with the 
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amorphous matrix. Figure 6c shows a larger crystal with similar bend contours, which are 
highlighted in the false color reconstructions (Figure 6d). 
Figure 6e contains both single crystals (orange circles) and nanocrystalline domains (yellow 
circles). The nanocrystalline domains in this region of the particle are more dispersed than those 
seen in Figure 4b, suggesting that, if also formed by the mechanical breakage mechanism, more 
time has elapsed since the event allowing the nanocrystals to further dissolve or distribute into 
the surrounding amorphous matrix. In the lower right of the Figure 6e, the orientation of the ~60 
nm crystal (also seen in the false color reconstructed image found in Figure 6f panel B) 
highlights a single lattice spacing in multiple orientations, suggesting that the crystal planes have 
been sheared with rotation in multiple orientations. Bend contours are also seen on one edge of 
the crystal, suggesting strain and deformation at the interface (this crystal edge is also seen in the 
false color reconstructed image found in Figure 6f panel C).
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Figure 6. (a) BF TE micrograph of an ASD particle with residual crystallinity. Amorphous 
channels show areas of advancing polymer content. (b) Discrete crystal with bend contours 
and corresponding FFT pattern (inset). (c) BF TE micrograph of multiple crystals showing 
strain at the interface. (d) Reconstructed BF TE micrographs from the inset of (c) 
generated using the Inverse FFT function in the Gatan Suite. Each of the areas A-D are 
colorized to indicate the location where those patterns appear in the original image (c). (e) 
BF TE micrograph showing multiple crystals and corresponding FFT pattern (inset). 
Domains in the 5-10 nm range are highlighted with yellow circles, and larger crystals are 
highlighted with orange circles. (f) Reconstructed BF TE micrographs from the inset of (e) 
generated using the Inverse FFT function in the Gatan Suite. Each of the areas A-D are 
colorized to indicate the location where those patterns appear in the original image (e).
Extrudate Characterization by Scanning Electron Microscopy
The interior of the extrudate rod was imaged for evidence of crystallinity (Figure 7) using 
scanning electron microscopy (SEM). Some regions of the extrudate appear fully amorphous 
(Figure 7a), as no clear features appear on the surface. Some regions have embedded crystals in 
the size range of 10-1000 µm (Figure 7b, c). Due to the resolution capability of the instrument, 
domains smaller than 10 nm could not be imaged.
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Figure 7. Scanning electron microscopy (SEM) images of the ASD extrudate. Some regions 
appear fully amorphous (a), or contain crystalline domains between 10-1000 nm (b, c). The 
length distribution of the domains found in (c) were measured as 38 ± 18 nm (± SD, n=100).
Comparison with X-ray Powder Diffraction
Ricarte et al. found that TEM was capable of detecting crystals in an X-ray amorphous 
physical mixture consisting of 3% crystalline drug,17 while a much greater degree of sensitivity 
was found in this analysis. There are many underlying reasons for the sensitivity limitations of 
X-ray diffraction. Because of the dilution of drug by the polymer in an ASD, crystallinity 
detection becomes more challenging because of the resulting reduction in signal intensity 
associated with the crystalline peaks.11,24 As crystallite size decreases, particularly into the 
nanometer range, peak broadening may limit detection of otherwise perfect crystals imbedded in 
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an amorphous matrix.25 Other sources of strain may influence peak detection, such as 
dislocations, stacking faults, and grain boundaries.26 In the ASD sample characterized here, as 
well as many samples in our previous work and others in the literature,6,27 crystalline content, as 
quantified by XRPD, may be systematically underestimated based on these factors.
Crystal Dissolution Initiated from Defect Sites
As the starting material of drug crystals is likely to contain imperfections and local disorder 
at the surface and in the bulk of the crystal,28,29 these defects are the likely sites for initiation of 
phase transformation due to thermal or mechanical stresses because of higher overall free energy 
resulting from the presence of mixed amorphous and crystalline phases. Chemical and thermal 
etching studies that have demonstrated that dissolution is initiated at defect sites30,31 and that 
dissolution rate correlates to defect density.32 Furthermore, contributions from the crystal 
structure, solvent-solid interactions, and the adsorption of the solvent molecule onto the crystal 
surface have been found to influence the dissolution mechanism at the crystal surface.33,34 The 
highly defective nanocrystalline domains imaged in this extrudate suggest that defects, both 
those intrinsic to the crystals and those formed by mechanical damage, propagate as the crystals 
dissolve into the amorphous matrix, resulting in size reduction of crystals both through 
dissolution of external crystal surfaces as well as through fragmentation. Thus, due to HME 
processing under high temperature and shear, loss of crystallinity (i.e. increase in crystal defects) 
is expected, as an intermediate stage of the crystalline-to-amorphous transformation by 
mechanical damage and dissolution into the molten polymer.
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Conclusions
Low levels of nanometer-scale residual crystals within a nominally amorphous drug-polymer 
dispersion prepared by hot melt extrusion were detected by transmission electron microscopy. 
This technique provided a high degree of sensitivity for the identification and microstructural 
characterization of two populations of nanocrystalline domains: single crystals <100 nm and 
clusters of 5-10 nm in size. The residual crystals show little similarity to the bulk crystalline 
starting material, as a result of thermally- and/or mechanically-induced structural deformation 
and dissolution into the amorphous matrix.
An open question remains whether or not any level, critical crystal size, or characteristic of 
residual crystals may be acceptable within ASDs, without causing detrimental stability or 
dissolution effects. The poor ability of common techniques to detect low levels of crystalline 
content contributes to the difficulty in addressing this question. The use of high resolution 
analytical techniques such as transmission electron microscopy to identify and characterize 
residual crystallinity is considered an important first step to understanding the significance of 
these residual crystalline populations to ASD performance attributes.
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Nanometer-Scale Residual Crystals in a Hot Melt Extruded Amorphous Solid Dispersion: 
Characterization by Transmission Electron Microscopy
Dana E. Moseson, Naila A. Mugheirbi, Andrew A. Stewart, Lynne S. Taylor
Synopsis
An amorphous solid dispersion produced by hot melt extrusion was determined to be fully 
amorphous by X-ray powder diffraction. Using transmission electron microscopy, amorphous 
and nanocrystalline domains (<100 nm) were observed. The nanocrystalline domains were found 
to have a high defect density.
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